Thyssen, Jacob P.
Zang, Chuanbo
Neary, Maureen P.
Bushmakin, Andrew G.
Cappelleri, Joseph C.
Cha, Amy
Russo, Christopher
Luger, Thomas A.
Clinical trials referenced in this document:
Documents that mention this clinical trial
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years
https://doi.org/10.1007/s40272-021-00490-y
Translating the Investigator’s Static Global Assessment to the Eczema Area and Severity Index in Studies of Crisaborole for Atopic Dermatitis
https://doi.org/10.1007/s13555-021-00509-9
Documents that mention this clinical trial
Subgroup Analysis of Crisaborole for Mild-to-Moderate Atopic Dermatitis in Children Aged 2 to < 18 Years
https://doi.org/10.1007/s40272-021-00490-y
Translating the Investigator’s Static Global Assessment to the Eczema Area and Severity Index in Studies of Crisaborole for Atopic Dermatitis
https://doi.org/10.1007/s13555-021-00509-9
Funding for this research was provided by:
Pfizer Inc
Article History
Received: 23 December 2020
Accepted: 25 February 2021
First Online: 13 March 2021